Last week, the Centers for Disease Control (CDC) and the Federal Drug Administration (FDA) released guidance related to the Zika Virus. The CDC released “Update: Interim Guidance for Health Care Providers Caring for Infants and Children with Possible Zika Virus Infection” earlier in the week. The FDA released “Recommendations for Donor Screening, Deferral, and Product Management to Reduce the Risk of Transfusion-Transmission of Zika Virus”. Both guidance documents are available below. Also included is the guidance that the CDC released in January pertaining to healthcare providers caring for pregnant women during the Zika virus outbreak.
The CDC is also recommending that part of the US that are at high-risk for Zika transmission start now with mosquito abatement programs – clean-up of standing water locations, planning for larviciding and targeting adult mosquitos, as well as initiating vector surveillance programs.
DSHS has also created a website www.texaszika.org which includes general information about Zika, including the latest surveillance data. The website will also link to current CDC guidance as it is released.